General Information of the Compound
| Compound ID |
CP0380893
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[[(2S)-2-[[(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-19-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C82H126N22O27S2
|
||||||||||||||||||
| Molecular Weight |
1916.171
|
||||||||||||||||||
| Canonical SMILES |
CCCC[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C82H126N22O27S2/c1-5-6-14-53(90-63(110)36-87-71(120)45(2)89-64(111)38-101-24-26-102(39-66(114)115)28-30-104(41-68(118)119)31-29-103(27-25-101)40-67(116)117)73(122)91-54(16-9-11-22-83)74(123)95-58(34-62(85)109)78(127)97-60-43-132-133-44-61(80(129)100-69(46(3)106)81(130)96-59(42-105)72(121)88-37-65(112)113)98-82(131)70(47(4)107)99-75(124)55(17-10-12-23-84)92-77(126)57(33-49-35-86-52-15-8-7-13-51(49)52)94-76(125)56(93-79(60)128)32-48-18-20-50(108)21-19-48/h7-8,13,15,18-21,35,45-47,53-61,69-70,86,105-108H,5-6,9-12,14,16-17,22-34,36-44,83-84H2,1-4H3,(H2,85,109)(H,87,120)(H,88,121)(H,89,111)(H,90,110)(H,91,122)(H,92,126)(H,93,128)(H,94,125)(H,95,123)(H,96,130)(H,97,127)(H,98,131)(H,99,124)(H,100,129)(H,112,113)(H,114,115)(H,116,117)(H,118,119)/t45-,46+,47+,53-,54-,55-,56-,57+,58-,59-,60-,61-,69-,70-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BREFCUWAHKPTKC-WQUXFBBMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00930, Somatostatin receptor type 1
Protein ID: PT01505, Somatostatin receptor type 2
Protein ID: PT01693, Somatostatin receptor type 3
Protein ID: PT01398, Somatostatin receptor type 4
Protein ID: PT01196, Somatostatin receptor type 5